Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.06.30.735466

Identification and Inhibition of GLUT like proteins in Trichuris spp as a druggable target

Abstract

Over a quarter of the worlds population is at risk of infection by soil transmitted helminths (STH). Among the STHs Trichuris trichiura infects approximately 7% of people globally, causing a loss of 232,000 DALYS. The main strategy to combat T. trichiura infection focusses on mass drug administration with the benzimidazoles. Whilst albendazole and mebendazole have been effective at reducing the burden of other STHs, the cure rate for whipworm is less than 50% with resistance alleles rising. Glucose is the most studied nutrient in Trichuris spp, however we have no understanding, at the molecular level of the mechanism of uptake in Trichuris spp. We sought to identify putative glucose transporters in Trichuris and investigate how these can be inhibited with phloretin. Using the C. elegans Facilitated Glucose Transporter 1 (FGT) sequence we identified two potential homologs in T. muris (TmGLT) and T. trichiura (TtGLT). We should both proteins contained sequence similarity to FGT1 and contained multiple sequence domains associated with glucose and sugar transport. Further, using Alphafold and molecular docking we show glucose docking sites consistent with transport. To asses the ability of phloretin to inhibit glucose transport, we also performed molecular docking with phloretin, showing possible inhibition. To validate the potential inhibition in vitro we measured the 48h LC50 of phloretin which we showed to be 111 ug/ml against adult T. muris worms, around half that of mebendazole in the same conditions. In contrast phloretin exhibited no effect on worm burden or fecundity in vivo. Together these findings provide the first in silico characterisation of putative glucose transporters in Trichuris spp and have identified glucose transport inhibition as a promising avenue for anthelminthic drug discovery. Whilst further work is required to optimise in vivo efficacy, our results highlight parasite glucose acquisition pathways as potential druggable targets in whipworm. Author SummaryOver a quarter of the worlds population is at risk of infection with soil-transmitted parasitic worms. One of these parasites, Trichuris trichiura (whipworm), infects millions of people worldwide. Current treatments rely on two drugs, albendazole and mebendazole, but these are much less effective against whipworm than other parasites, and there is growing concern about resistance. This highlights the need for new treatment strategies. In this study, we investigated how whipworms take up glucose, an essential energy source required for survival. Using computational approaches, we identified candidate glucose transporter proteins in both the human parasite (T. trichiura) and a laboratory model species (T. muris). We then tested whether these proteins could be targeted using the compound phloretin. Our results suggest that phloretin may block glucose uptake at the molecular level, and we show that it reduces worm survival in laboratory experiments. However, it did not have the same effect in animal infections. Together, our findings identify glucose uptake as a potential weakness in whipworms and provide a starting point for developing new treatments.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Turner, M. J., Palinski, J., Else, K. J., Moore, K. L.. 2026-06-30. Identification and Inhibition of GLUT like proteins in Trichuris spp as a druggable target. https://doi.org/10.64898/2026.06.30.735466

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A population-scale landscape of the subgingival microbiome reveals divergent routes to periodontal dysbiosis

Periodontitis is an archetypical mucosal inflammatory disease in which microbiome dysbiosis at the tooth-epithelial interface interacts with host genetic and behavioral risk factors to drive immune-mediated tissue destruction. Although subgingival microbiome compositional shifts are thought to parallel disease severity, microbiome variation at the population-level and its relationship to periodontal clinical phenotypes and disease-modifying factors remain poorly defined. Here, we use unsupervised manifold learning to map the compositional landscape of the subgingival microbiome in 1,355 adults spanning periodontal health to severe periodontitis. We identified eight latent microbiome states organized along a branching continuum from eubiosis to dysbiosis. An intermediate microbial configuration marked ecological destabilization and bifurcation into two distinct periodontitis-associated dysbiotic trajectories, distinguished by links to gingival inflammation and smoking. Although the microbiome trajectories broadly tracked periodontal destruction, a minority of individuals showed discordant microbiome-clinical phenotypes, with some individuals with periodontitis retaining otherwise eubiotic microbiomes enriched for low-abundance pathobionts, while some cases of health or mild disease had highly dysbiotic communities, suggesting distinct host susceptibility. Together, these findings define a population-scale ecological landscape of the subgingival microbiome, reveal divergent trajectories to periodontal dysbiosis, and highlight heterogeneity in the relationship between microbial community structure and clinical disease expression.

microbiology↗

Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point

Methicillin-resistant Staphylococcus aureus (MRSA) is non-susceptible to beta-lactams. Blockade of cell wall biosynthesis is a potential target for beta-lactam enhancement but requires further investigation. A butyrolactone derivative enhanced beta-lactams against MRSA strains by reducing the availability of D-Ala-D-Ala. Unlike D-cycloserine, it did not inhibit D-Ala-D-Ala ligase (Ddl). Nor did it show an additive or synergistic effect when combined with cycloserine, indicating a unique mechanism for blocking cell wall precursor production that does not involve the traditional Lipid II pathway. Notably, beta-lactam potentiation by our chemical or D-cycloserine was highly dependent on the intrinsic autolytic ability of the tested MRSA strains. Strains that resisted lysis upon Triton X-100 exposure showed a minimal increase in beta-lactam susceptibility, whereas highly autolytic strains showed significant changes in their beta-lactam MICs. We have thus identified autolytic ability as the Achilles Heel in the strategy of targeting cell wall biosynthesis for beta-lactam potentiation.

microbiology↗

Rapid and largely reversible shifts in the canine fecal metabolome during dietary change

Diet can rapidly change the fecal metabolome, but less is known about recovery after the original diet is restored. We used untargeted UPLC-MS metabolomics to analyze 72 fecal samples from nine Pumi dogs during an owner-managed switch from dry food to raw food and back to dry food. Diet phase accounted for a large proportion of variation in both ionization modes. More than 13,000 LC-MS features changed at the first sampling point after the switch to raw food, with a similarly large response after return to dry food. Among features significant in both comparisons, more than 99% changed in opposite directions. At the final sampling point, no positive-mode (ESI+) features and only 13 negative-mode (ESI-) features differed from the second dry-food baseline under the same threshold. BARF-associated patterns persisted in analyses excluding individual dogs and in pedigree-adjusted candidate models, although individual feature effects depended on normalization. Putative metabolites from several biochemical classes differed in their response and recovery. The fecal metabolome therefore changed rapidly and returned largely toward baseline, with differences among dogs.

microbiology↗